ViewRay (NSDQ:VRAY) said yesterday that it won FDA 510(k) clearance to offer soft tissue visualization capabilities with its MRIdian system. The newly cleared features include expanded high-definition visualization and contrast between tissues, diffusion weighted imaging for improved distinguishing between normal and tumor tissues and more detailed, brighter and faster anatomical planar imaging, the Cleveland-based company said. […]
Senseonics CFO Elsey to retire | Personnel Moves – December 4, 2018
Senseonics (NYSE:SENS) said yesterday that its CFO R. Elsey is retiring for the company, and that it has begun searching for a permanent replacement. The Germantown, Md.-based company said that Elsey will stay on until a replacement is appointed, and remain on in an advisory role through to the completion of the company’s 2018 fiscal […]
ASTRO 2018 Roundup: Fujifilm enters US CT market with FCT Embrace
Fujifilm (TSE:4901) said this week it launched the FCT Embrace 85cm wide bore computed tomography imaging unit, touting it as the world’s first such device to hit the market. The system launch marks the company’s first foray into the CT field, FujiFilm said. The release was announced at the American Society for Radiation Oncology annual meeting […]
BD promotes Polen to COO | Personnel Moves – October 3, 2018
Becton Dickinson (NYSE:BDX) said today it named current president Tom Polen as its new chief operating officer, filling a role that has been empty since 2016. Polen was appointed president in April 2017, and will continue to report to chairman and CEO Vincent Forlenza, the Franklin Lakes, N.J.-based company said. In his new position, Polen will […]
ViewRay closes $173m offering
ViewRay (NSDQ:VRAY) today closed a $172.5 million offering with funds slated to support working capital and general corporate purposes. In the offering, the Cleveland-based company floated approximately 16.2 million shares of common stock at $9.25 per share, bringing in $150 million gross before offering-related payments. The offering also included 30-day underwriter’s option to purchase an additional 2.4 […]
ViewRay prices $150m offering
ViewRay (NSDQ:VRAY) yesterday priced an upcoming offering looking to raise $150 million. The Cleveland-based company plans to float approximately 16.2 million shares of common stock at $9.25 per share, bringing in $150 million gross before offering-related payments. The offering, slated to close on August 17, will also include a 30-day underwriter’s option to purchase an additional 2.4 […]
ViewRay picks up ex-Spectranetics CEO Drake, COO Matin | Personnel Moves – July 25, 2018
ViewRay (NSDQ:VRAY) said yesterday it tapped former Spectranetics head Scott Drake as its new chief executive officer and former Spectranetics COO Shar Matin as its new COO. Before joining ViewRay, Drake served as CEO and prez of Spectranetics, which was acquired by Royal Philips (NYSE:PHG) in a deal that closed last August. Drake also serves as board chair […]
ViewRay shares dip despite Q1 earnings Beat
Shares in ViewRay (NSDQ:VRAY) fell today despite the medical device maker posting first quarter earnings that beat expectations on Wall Street. The Cleveland-based company posted losses of $7.5 million, or 11¢ per share, on sales of $26.2 million for the three months ended March 31, seeing losses shrink 73% while sales grew over 2000% compared with […]
ViewRay wins Japanese approval for MRIdian Linac system
ViewRay (NSDQ:VRAY) said today it won Japanese Ministry of Health, Labor and Welfare Shonin approval for its MRIdian Linac linear accelerator system. The newly cleared MRIdian Linac device replaces the cobalt it utilized with linear accelerator technology, the Cleveland, Ohio-based company said. The company won FDA approval for the device last February. ViewRay touted the MRIdian as the […]
ViewRay adds another $59m from Chinese backer Fosun
ViewRay (NSDQ:VRAY) said it added another $59.1 million it its coffers in an equity and warrants sale to Chinese investment firm Fosun International, following a $50 million offering last year. Fosun, which took out a 9.9% stake in ViewRay last October in a $50 million round, is slated to own 18.4% of the Cleveland-area linear accelerator […]
ViewRay raises $50m
ViewRay (NSDQ:VRAY) said today it raised $50 million in a new direct offering to support ongoing commercialization of its MRIdian linear accelerator technology and further research & development. In the offering, the Cleveland, Ohio-based company floated approximately 8.4 million shares of its common stock at $5.95 per share, while affiliates of the company paid $6.44 per share. […]
- 1
- 2
- 3
- 4
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube